Results 41 to 50 of about 6,409 (180)
Relapses, Comorbidities, and Predictors of Outcome in Anti‐GABAA Receptor Encephalitis
Objectives To characterize the magnetic resonance imaging (MRI) lesion dynamics, comorbidities, predictors of relapse, and outcomes in anti‐γ‐aminobutyric acid type A receptor (GABAAR) encephalitis, and assess the utility of LIM‐domain‐only‐protein 5 (LMO5) antibodies as tumor markers.
Claudia Papi +33 more
wiley +1 more source
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a type of limbic encephalitis that is resulted by an autoimmune processes; it is a rare autoimmune encephalitis caused by the NMDA receptor antibody secreted by all kinds of tumors.
S.H. Park +5 more
doaj +1 more source
Herpes simplex virus encephalitis (HSVE) is the most common cause of encephalitis with very high rates of mortality. Only 40 cases of postoperative HSVE have been reported; most authors agree it might be reactivation secondary to surgical stress and ...
Diego F. Gomez +5 more
doaj +1 more source
Abstract Objective We investigated the presence and potential functional relevance of antimitochondrial autoantibodies in patients suspicious for autoimmune encephalitis (AIE) associated with psychiatric symptoms and/or seizures, who were negative for known antineuronal autoantibodies.
Annika Breuer +12 more
wiley +1 more source
Relapse risk factors in anti‐N‐methyl‐D‐aspartate receptor encephalitis [PDF]
AimTo identify factors that may predict and affect the risk of relapse in anti‐N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis.MethodThis was a retrospective study of an Italian cohort of patients with paediatric (≤18y) onset anti‐NMDAR encephalitis.ResultsOf the 62 children included (39 females; median age at onset 9y 10mo, range 1y 2mo–18y; onset ...
Nosadini, Margherita +53 more
openaire +11 more sources
Abstract Objective Epilepsy is a highly heterogeneous neurological disorder with significant prognostic variability. Accurate long‐term outcome prediction remains a clinical challenge. We investigated pharmacotherapeutic prognosis and key predictors, particularly baseline seizure timing, to guide individualized treatment.
Lei Sun +3 more
wiley +1 more source
Overlapping demyelinating syndromes and anti–N‐methyl‐D‐aspartate receptor encephalitis [PDF]
Objective To report the clinical, radiological, and immunological association of demyelinating disorders with anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis. Methods Clinical and radiological analysis was done of a cohort of ...
Titulaer, Maarten J. +20 more
openaire +3 more sources
Mendelian randomization (MR) studies were conducted using the inverse‐variance weighted (IVW) method, MR‐Egger and weighted median on juvenile myoclonic epilepsy (JME), and systemic lupus erythematosus (SLE) data from the Integrative Epidemiology Unit (IEU) Open genome‐wide association study (GWAS) database and the International League Against Epilepsy
Sirui Chen +10 more
wiley +1 more source
Late relapse of anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis: a case report
Background Anti-N-methyl-d-aspartate receptor encephalitis is a sporadic autoimmune disorder of the brain that presents in a variety of neuropsychiatric manifestations, including seizures, psychosis, and alterations in behavior.
Hamidreza Amiri +2 more
doaj +1 more source
Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is the most common form of autoimmune encephalitis, caused by the interaction between an antibody and its target, located on glutamate receptor type N-methyl-D-aspartate (NMDA) of neuronal surface ...
Claudia Geraldine Rita +3 more
doaj +1 more source

